Market Movers

China Life Insurance’s stock price soars to 23.52 HKD, witnessing a robust increase of 2.44%

By October 20, 2025 No Comments

China Life Insurance (2628)

23.52 HKD +0.56 (+2.44%) Volume: 110.25M

China Life Insurance’s stock price is currently at 23.52 HKD, witnessing a positive trading session with a rise of 2.44%, backed by a robust trading volume of 110.25M. The stock’s performance remains strong with a Year-to-Date (YTD) percentage change of +59.81%, making it a standout in the insurance sector.


Latest developments on China Life Insurance

China Life Insurance Company Limited (CHL) has been in the spotlight recently with significant developments impacting its stock price. The company projects substantial profit growth for 2025, expecting profits to increase by up to 70 percent in the first three quarters. Additionally, China Life’s Liu Anlin has been expelled from the Communist Party, adding a layer of intrigue to the company’s internal dynamics. Investors are closely watching how forex fluctuations and the company’s earnings guidance for the nine months ending in September 2025 will influence CHL stock movements. With comparisons to its peers and discussions on whether the stock is undervalued or poised for a strong rally, China Life Insurance Company Limited remains a key player in the market.


China Life Insurance on Smartkarma

Analysts on Smartkarma, like Alec Tseung, are bullish on China Life Insurance Company. In a recent research report titled “Two Asian Life Insurance Stocks (Both Up >30% YTD) Worth Closer Looks”, it was highlighted that China Life’s agency restructuring is starting to show positive results, leading to an increase in agency productivity. This is expected to drive new business growth and margin expansion for the company. Despite years of underperformance, China Life is now on the path to recovery, with its share price up by 33% YTD.

The research report also mentioned that Prudential plc, another company in the life insurance sector, is also experiencing a positive trend with its share price up by 40% – 50% YTD. The analysts believe that Prudential’s multiple is on the right track of re-rating, indicating potential valuation upside. Overall, the outlook for both China Life Insurance Company and Prudential plc remains optimistic, with the analysts maintaining their bullish stance on these companies.


A look at China Life Insurance Smart Scores

FactorScoreMagnitude
Value3
Dividend3
Growth5
Resilience4
Momentum5
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Life Insurance Company Ltd. offers a wide range of life, accident, and health insurance products and services. According to Smartkarma Smart Scores, the company has a strong outlook for growth and momentum, scoring 5 in both categories. This suggests that China Life Insurance Company is well-positioned to expand its market presence and continue to perform well in the future.

Additionally, China Life Insurance Company scores well in resilience, with a score of 4, indicating its ability to withstand economic challenges and navigate uncertainties. While the value and dividend scores are rated at 3, showing a moderate performance in these areas, the overall outlook for China Life Insurance Company appears positive, particularly in terms of growth and momentum.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars